Torrent Carbamazepine Tablets 200mg Recall: Failed Dissolution Specifications
Torrent Pharma recalls 200mg Carbamazepine tablets with failed dissolution specs. Rx-only 500-count bottles may not release medication properly. Consumers should contact pharmacy for guidance.
Lower-risk recall
Failed Dissolution Specifications
Contact the company
What happened, in plain English
Torrent Pharma recalls 200mg Carbamazepine tablets in 500-count bottles due to failed dissolution specifications. This means the tablets may not release medication properly as intended, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/37127-torrent-carbamazepine-tablets-200mg-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/37127-torrent-carbamazepine-tablets-200mg-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-1317-2020
Cite this page
“Torrent Carbamazepine Tablets 200mg Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37127-torrent-carbamazepine-tablets-200mg-recall-failed-dissolution-specifications. Based on FDA recall #D-1317-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1317-2020%22&limit=1).
Why it’s dangerous
The tablets failed to dissolve properly during testing, which could mean they don't release medication as intended. This might lead to inconsistent dosing or treatment effectiveness, but does not cause immediate harm.
Who’s affected
Prescription patients using Carbamazepine tablets for conditions like seizures or nerve pain. Those with the specific NDC 13668-268-05 lot number 4FF4F001 are most at risk.
How to tell if you have this one
Check for the 500-count bottle labeled 'Carbamazepine Tablets, USP 200 mg' with NDC 13668-268-05 and lot number 4FF4F001. This product is prescription-only and manufactured by Torrent Pharmaceuticals.
- Brand
Torrent- Category
Drug
What to do — step by step
Contact Pharmacy
Talk to your pharmacist about whether you have the recalled tablets and how to proceed with your treatment.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class II
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have the recalled product?
Contact your pharmacist for advice on next steps. The recall does not include a specific return or disposal instruction.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1317-2020 (May 11, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1317-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.